Senior Director, Global & Health Outcomes Research Lead, Rsv Vaccines

Locations: GSK HQ UK, New Oxford Street or USA - Upper Providence or Wavre, Belgium
Reporting to: Executive Director & TA Head-Vaccines

The CPO organisation partners closely with R&D and Commercial to translate cutting-edge science into measurable health outcomes, grounded in the patient voice and external insights from healthcare systems and decision-makers worldwide. Joining CPO means working across the full product lifecycle and collaborating with diverse expert teams – from Patients & External Environment and Medical Planning to Data Generation, Scientific Communications, Medical Impact, Proactive Risk Ownership and Integrated Evidence Strategy – to ensure robust evidence, clear medical insight and responsible risk ownership shape strategy and execution 's a highly visible, purpose-driven environment where your expertise can directly influence how innovative therapies are developed, communicated and used to improve lives around the world.

The role of Senior Director, Global Real-World Evidence & Health Outcomes Research (GRWE& HO) Lead is critical to achieving this ambition by ensuring that each vaccine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing. The role is essential for the alignment of evidence with the requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use and commercial success.

The role will serve as single point accountable lead for RSV vaccines, including stand alone and combination assets, in market and pre-launch. The role will be a key member of the Global Real-World Evidence & Health Outcomes Research Vaccines LT and other relevant matrix leadership teams. The Senior Director, Global Real-World Evidence & Health Outcomes Research Lead will be accountable for ensuring team members engage closely with medical and matrix stakeholders and partner effectively in data generation plan (DGP) planning, design, execution, translation, and dissemination for the asset.

• Provide leadership, management, and development of Data Generation book of work.
• Partner effectively with matrix stakeholders in planning and design of the DGP for the asset, drive disciplined execution of studies and activities, translate results, and disseminate data and research findings to all relevant internal and external stakeholders.
• Provide scientific leadership for best practice in real world evidence study methodologies, leveraging diverse methodological approaches to meet unique product challenges with innovative evidence solutions.
• Drive innovation and inform ideas and options through effective engagement with external experts, clinical guideline groups, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment to enable more efficient evidence development for the asset across the lifecycle (e.g. discovery, launching and life cycle management assets)
• Integrate excellent understanding of the evolving global NITAG bodies, clinical guidelines groups, policy decision makers and payer environment, including recommendation, reimbursement, pricing, and access associated with vaccines.
• Lead discussions with key stakeholders on prioritization of evidence generation in order to meet business and customer needs.
• Deliver the materials to inform internal governance decision making (e.g. Medical Review Board, etc)
• Facilitate alignment and partnership to enable more…